Drug makers called out for delaying generics have cost Medicare and Medicaid billions

Makers of brand-name drugs called out by the Trump administration for potentially stalling generic competition have hiked their prices by double-digit percentages since 2012 and cost Medicare and Medicaid nearly $12 billion in 2016, a Kaiser Health News analysis found.

     

 

 

from USATODAY - News Top Stories https://ift.tt/2x7yhr2